Cargando…
Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa
BACKGROUND: Dystrophic epidermolysis bullosa (DEB), a rare genodermatosis, is characterized by the formation of intra-epidermal blistering and the development of chronic nonhealing skin wounds. Recently, attempts have been made to develop cell-based therapies for this currently intractable disorder....
Autores principales: | Alexeev, Vitali, Donahue, Adele, Uitto, Jouni, Igoucheva, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002132/ https://www.ncbi.nlm.nih.gov/pubmed/27568180 http://dx.doi.org/10.1186/s13287-016-0388-y |
Ejemplares similares
-
Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa
por: Huitema, Leonie, et al.
Publicado: (2021) -
T‐cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients
por: Alexeev, Vitali, et al.
Publicado: (2022) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020
por: Has, Cristina, et al.
Publicado: (2020) -
Pretibial dystrophic epidermolysis bullosa
por: Callegaro, Elisabeth de Albuquerque Cavalcanti, et al.
Publicado: (2017)